financetom
Business
financetom
/
Business
/
Air Products and Chemicals Issues Downbeat Full-Year Outlook Following Mixed Quarterly Results
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Air Products and Chemicals Issues Downbeat Full-Year Outlook Following Mixed Quarterly Results
Nov 9, 2024 12:14 PM

09:33 AM EST, 11/07/2024 (MT Newswires) -- Air Products and Chemicals ( APD ) on Thursday provided a fiscal 2025 earnings guidance that missed Wall Street's estimates as the industrial gases company's fourth-quarter earnings rose more than expected while revenue unexpectedly remained flat.

Full-year adjusted earnings are expected to come in between $12.70 and $13 per share. The consensus on Capital IQ is for normalized EPS of $13.33 for the current fiscal year.

For the first quarter, the company expects adjusted EPS in the range of $2.75 to $2.85, while the current consensus is $3.15.

"We are not forecasting any significant growth for this quarter due to our concerns about the economic activity in China," Chief Executive Seifi Ghasemi said on an earnings conference call, according to a Capital IQ transcript. "It is possible that economic activity in China might improve with actions that the Chinese government might take in the future, but we have not included that in our forecast."

The company expects capital expenditures in the range of $4.5 billion to $5.0 billion in fiscal 2025, compared with $5.15 billion in the year ended September.

For the three months ended Sept. 30, Air Products' adjusted earnings gained 13% year over year to $3.56 a share, ahead of the Street's view for $3.48. Sales came in at $3.19 billion, below the consensus estimate of $3.23 billion. The metric was largely flat year over year as higher volume and pricing were offset by lower energy cost pass-through.

Revenue in the Americas fell 3% from last year to $1.31 billion, while Europe rose 3% to $730.9 million. Sales in Asia jumped 7% to $861.2 million.

Price: 307.06, Change: +0.33, Percent Change: +0.11

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Largo Down More Than 50% In US Premarket As Announces Pricing of Registered Direct Offering and Private Placement, Reliance On Financial Hardship Exemption
Largo Down More Than 50% In US Premarket As Announces Pricing of Registered Direct Offering and Private Placement, Reliance On Financial Hardship Exemption
Oct 15, 2025
09:14 AM EDT, 10/15/2025 (MT Newswires) -- Largo (LGO.TO and NASDAQ: LGO) was at last look down more than 50% and at 52 week lows levels as its entered Wednesday into securities purchase agreements with institutional and accredited investors for the purchase and sale of 14,262,309 common shares of the company at a purchase price of US$1.22 per common share...
Plumas Bancorp beats Q3 EPS estimates despite income drop
Plumas Bancorp beats Q3 EPS estimates despite income drop
Oct 15, 2025
Overview * Plumas Bancorp ( PLBC ) beats analysts' expectations for Q3 EPS despite decline in net income * Company's Q3 results were influenced by Cornerstone acquisition, which increased assets and deposits * Net interest income rose by $6.3 mln in Q3 2025 Outlook * Company expects cost of funds to decrease slightly following recent changes and Fed rate reduction...
Prologis tops quarterly estimates on strong warehouse leasing
Prologis tops quarterly estimates on strong warehouse leasing
Oct 15, 2025
Oct 15 (Reuters) - Warehouse-focused real estate investment trust Prologis ( PLD ) beat Wall Street estimates for third-quarter revenue and funds from operations on Wednesday, helped by robust demand for its storage facilities. The San Francisco, California-based company also raised its 2025 core FFO forecast to a range of $5.78 per share to $5.81 per share, from $5.75 per...
Scynexis to Receive $22 Million Resolving Disagreement With GSK Over Phase 3 Mario Study; Shares Rise Pre-Bell
Scynexis to Receive $22 Million Resolving Disagreement With GSK Over Phase 3 Mario Study; Shares Rise Pre-Bell
Oct 15, 2025
09:14 AM EDT, 10/15/2025 (MT Newswires) -- Scynexis ( SCYX ) said Wednesday it will receive a $22 million payment from GSK's (GSK) GlaxoSmithKline Intellectual Property (No. 3) Limited, resolving the disagreement related to the restart of the phase 3 Mario study on invasive candidiasis. As per resolution terms, Scynexis ( SCYX ) will terminate the Mario study and receive...
Copyright 2023-2026 - www.financetom.com All Rights Reserved